FETAL HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 3 (HUMAN)

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 21:58:18 GMT 2025` Edited by `admin` on `Mon Mar 31 21:58:18 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	9971WH3C6O
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FETAL HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 3 (HUMAN)

Common Name

English

DIMETHYLANILINE MONOOXYGENASE (N-OXIDE-FORMING) 3 (HUMAN)

Preferred Name

English

FMO 3 (HUMAN)

Common Name

English

DIMETHYLANILINE OXIDASE 3 (HUMAN)

Common Name

English

Code System Code Type Description

UNIPROT

P31513

Created by admin on Mon Mar 31 21:58:18 GMT 2025 , Edited by admin on Mon Mar 31 21:58:18 GMT 2025

PRIMARY

FDA UNII

9971WH3C6O

Created by admin on Mon Mar 31 21:58:18 GMT 2025 , Edited by admin on Mon Mar 31 21:58:18 GMT 2025

PRIMARY

CAS

479965-98-5

Created by admin on Mon Mar 31 21:58:18 GMT 2025 , Edited by admin on Mon Mar 31 21:58:18 GMT 2025

PRIMARY

Related Record Type Details


					N7U69T4SZR

Olanzapine

SUBSTRATE -> METABOLIC ENZYME

Amount:


					5T4CV1RG0H

S-16020

SUBSTRATE -> METABOLIC ENZYME

Amount:


					WX8LOM674D

NELONICLINE

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR


					MMG78X7SSR

AMITHIOZONE

SUBSTRATE -> METABOLIC ENZYME

Amount:


					76RS4S2ET1

Risdiplam

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR

Amount:


					1C058IKG3B

Teriflunomide

NON-SUBSTRATE -> METABOLIC ENZYME


					4784C8E03O

TRICLABENDAZOLE

SUBSTRATE -> METABOLIC ENZYME


					YO460OQ37K

VANDETANIB

SUBSTRATE -> METABOLIC ENZYME


					MZ4Y5H4OAB

C-1311

SUBSTRATE -> METABOLIC ENZYME


					9BJL40ZG18

ABT-418-N-OXIDE, S-CIS-

SUBSTRATE -> METABOLIC ENZYME


					6L1XP550I6

FEDRATINIB

SUBSTRATE -> METABOLIC ENZYME

Comments:

Metabolized by CYP3A4 (0 to 70%), CYP2C19 (0?20%), and FMO3 (0?33%) in vitro.

Amount:


					QUY32964DJ

ANETHOLTRITHION

SUBSTRATE -> METABOLIC ENZYME


					NQU9IPY4K9

CEDIRANIB

SUBSTRATE -> METABOLIC ENZYME


					1LGS5JRP31

NOMIFENSINE

SUBSTRATE -> METABOLIC ENZYME

Amount:


					3MAE0MXI6K

TG-100435

SUBSTRATE -> METABOLIC ENZYME


					Y180U02GSB

MK-0767

SUBSTRATE -> METABOLIC ENZYME


					X78UG0A0RN

DASATINIB ANHYDROUS

SUBSTRATE -> METABOLIC ENZYME


					85FDJ14553

TAZAROTENIC ACID

SUBSTRATE -> METABOLIC ENZYME

Amount:


					234335M86K

TOZASERTIB

SUBSTRATE -> METABOLIC ENZYME


					F4216019LN

ALBENDAZOLE

SUBSTRATE -> METABOLIC ENZYME

Amount:


					WH2PZ15PPN

C-1330

SUBSTRATE -> METABOLIC ENZYME


					JFU09I87TR

VORICONAZOLE

SUBSTRATE -> METABOLIC ENZYME


					OAY8ORS3CQ

ETHIONAMIDE

SUBSTRATE -> METABOLIC ENZYME

Amount:


					07896928ZC

ERAVACYCLINE

SUBSTRATE -> METABOLIC ENZYME

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_400]		S		DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL